Xintian Pharmaceutical: Net profit in 2025 was 9.1115 million yuan, a year-on-year decrease of 82.59%.

Sina Finance reported on March 30th that Xintian Pharmaceutical announced that its operating income for 2025 was 750 million yuan, a year-on-year decrease of 12.57%. Net profit was 9.11 million yuan, a decrease of 82.59% compared to the previous year. The profit distribution plan approved by the company's board of directors is to distribute a cash dividend of 0.30 yuan for every 10 shares to all shareholders, without bonus shares or capital reserve increase.